Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
Study Details
Study Description
Brief Summary
The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (~ 15% O2, similar to conditions at an altitude of ~7500 feet) will improve glucose metabolism.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Early Phase 1 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Hypoxia Exposure There was only one study arm: All participants slept in moderate hypoxia (see description below). |
Other: Hypoxia Exposure
Participants spent 10 consecutive nights (approximately 100 hours of exposure) in a hypoxic tent at ~ 15% O2 (ca. 2400 m elevation).
|
Outcome Measures
Primary Outcome Measures
- Change in Insulin sensitivity [Change from baseline to 10 nights of hypoxia exposure]
Glucose disposal and oxidation were measured using a two-step hyperinsulinemic euglycemic clamp and indirect calorimetry.
Secondary Outcome Measures
- Change in oxygen tension in adipose tissue [Before and after 10 nights of hypoxia exposure]
pO2 levels were measured in adipose tissue both under hypoxia and normal oxygen conditions (normoxia) via a dual temperature-oxygen tension probe.
- Glucose uptake in myotubes [Before 10 nights of hypoxia exposure]
Glucose uptake assays were performed in the presence or absence of hypoxia on myotubes harvested from muscle biopsies.
- Change in gene and protein expression [Before and after 10 nights of hypoxia exposure]
Gene and protein expression of some hypoxia-responsive and insulin-signaling markers were measured in biopsied muscle and adipose tissue via RT-PCR and Western blotting, respectively.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged 20-45 years
-
Male
-
Obese category (BMI > 30 kg/m2)
-
Healthy as assessed by a self-reported health questionnaire
-
Non-smokers
-
Weight stable over the past 3 months (<2kg fluctuation)
Exclusion Criteria:
-
Female
-
Diabetes
-
Sleep apnea
-
Hypertension
-
History of altitude sickness
-
Individuals taking any chronic medications
-
Individuals taking any stimulants
-
Individuals taking beta-blockers
-
Individuals with chronic alcohol consumption (>3 drinks per day) or drug abuse.
-
Individuals unable to abstain from caffeinated beverage or alcohol the days of study testing
-
Individuals with history disease or history of stroke
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pennington Biomedical Research Center | Baton Rouge | Louisiana | United States | 70808 |
Sponsors and Collaborators
- Pennington Biomedical Research Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PBRC 11009